http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0971728-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5181f7bc41146d952cf4e72f866a39ca
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-141
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S930-14
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1793
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2086
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-02
filingDate 1998-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3aeb6d7634a866d2b1738e3be665821f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bbb4c538b9158654a5b3a5c20071aa6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e7da7fa42e4743b260ab333d48a0ea54
publicationDate 2002-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0971728-B1
titleOfInvention Use of interleukin-15
abstract The invention relates to the use of IL-15 inhibiting or eliminating compounds that interfere with the binding of IL-15 to its receptor for the manufacture of a pharmaceutical composition for suppression of formation of CD4<+> memory cells of the immune system. Such inhibiting or eliminating compounds are for example anti-IL-15 antibodies, anti-IL-15R alpha antibodies, fragments of these antibodies, e.g. the Fab or F(ab')2 fragment, soluble IL-15R alpha , fusion proteins consisting of soluble IL-15R alpha , and Fc fragment, compounds, e.g. peptides, binding and/or inhibiting functional IL-15 receptor, IL-15 antisense oligonucleotides.
priorityDate 1997-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400161
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31264
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124886
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395874
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395791
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393724
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID745
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411781
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5746
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54676860
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104981
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405512
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335613
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400160

Total number of triples: 34.